1-9 of 9
Authors: D. Portman
Journal Article
012 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Page S224, https://doi.org/10.1016/j.jsxm.2020.04.248
Published: 01 July 2020
Journal Article
038 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Page S237, https://doi.org/10.1016/j.jsxm.2020.04.274
Published: 01 July 2020
Journal Article
011 Correlation Between Validated Instruments Used in the RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Pages S223–S224, https://doi.org/10.1016/j.jsxm.2020.04.247
Published: 01 July 2020
Journal Article
020 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With Hypoactive Sexual Desire Disorder Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_1, January 2020, Pages S9–S10, https://doi.org/10.1016/j.jsxm.2019.11.023
Published: 01 January 2020
Journal Article
194 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies Get access
The Journal of Sexual Medicine, Volume 17, Issue Supplement_1, January 2020, Page S67, https://doi.org/10.1016/j.jsxm.2019.11.191
Published: 01 January 2020
Journal Article
017 Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD) in the RECONNECT Study: Efficacy Analyses in Study Completers and Responders Get access
The Journal of Sexual Medicine, Volume 14, Issue Supplement_5, June 2017, Pages e356–e357, https://doi.org/10.1016/j.jsxm.2017.04.023
Published: 01 June 2017
Journal Article
021 Correlation of Physiologic Markers of Vulvovaginal Atrophy and Symptom Severity in Postmenopausal Women with Genitourinary Syndrome of Menopause Get access
The Journal of Sexual Medicine, Volume 13, Issue Supplement_6, June 2016, Page S248, https://doi.org/10.1016/j.jsxm.2016.04.021
Published: 01 June 2016
Journal Article
014 A Phase 2 Program on Female Sexual Arousal Disorder and Hypoactive Sexual Desire Disorder: Patient Characteristics and Implications for Diagnosis and Treatment of Female Sexual Dysfunction Get access
The Journal of Sexual Medicine, Volume 13, Issue Supplement_6, June 2016, Pages S244–S245, https://doi.org/10.1016/j.jsxm.2016.04.014
Published: 01 June 2016
Journal Article
009 Lasofoxifene, a Selective Estrogen Receptor Modulator, as a Treatment for Sexual Dysfunction in Postmenopausal Women Get access
The Journal of Sexual Medicine, Volume 13, Issue Supplement_1, May 2016, Pages S4–S5, https://doi.org/10.1016/j.jsxm.2016.02.011
Published: 01 May 2016
